Brain subtyping enhances the neuroanatomical discrimination of schizophrenia

Schizophrenia Bulletin

Volumn 44, Issue 5, 2018, Pages 1060-1069

  Dwyer, Dominic B ^a   Cabral, Carlos ^a   Kambeitz Ilankovic, Lana ^a   Sanfelici, Rachele ^a   Kambeitz, Joseph ^a   Calhoun, Vince ^b,c   Falkai, Peter ^a   Pantelis, Christos ^d   Meisenzahl, Eva ^a   Koutsouleris, Nikolaos ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b Lovelace Biomedical and Environmental Research Institute   (United States)

^c MSC01 1070   (United States)

^d UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Clustering; Machine learning; MRI; Schizophrenia; Staging; Subtype; Unsupervised9

Indexed keywords

ACCURACY; ADULT; ARTICLE; BRAIN ANALYSIS; BRAIN CORTEX; BRAIN SIZE; COGNITION; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE DURATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEGATIVE SYNDROME; NEUROANATOMY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROOF OF CONCEPT; SCHIZOPHRENIA; SUBCORTEX; SUPERVISED MACHINE LEARNING; SYMPTOM ASSESSMENT; UNSUPERVISED MACHINE LEARNING; BRAIN; CLASSIFICATION; DIAGNOSTIC IMAGING; IMAGE PROCESSING; MACHINE LEARNING; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; PROCEDURES; YOUNG ADULT;

ADULT; BRAIN; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MACHINE LEARNING; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; SCHIZOPHRENIA; YOUNG ADULT;

EID: 85055132307     PISSN: 05867614     EISSN: 17451701     Source Type: Journal    
DOI: 10.1093/schbul/sby008     Document Type: Article

References (59)

1. Kapur S, Phillips AG, Insel TR. Why has it taken so long for biological psychiatry to develop clinical tests and what to do about it? Mol Psychiatry. 2012;17:1174-1179.
2. Kambeitz J, Kambeitz-Ilankovic L, Leucht S, et al. Detecting neuroimaging biomarkers for schizophrenia: a meta-analysis of multivariate pattern recognition studies. Neuropsychopharmacology. 2015;40:1742-1751.
3. Klöppel S, Abdulkadir A, Jack CR Jr, Koutsouleris N, Mourão-Miranda J, Vemuri P. Diagnostic neuroimaging across diseases. Neuroimage. 2012;61:457-463.
4. Koutsouleris N, Meisenzahl EM, Davatzikos C, et al. Use of neuroanatomical pattern classification to identify subjects in at-risk mental states of psychosis and predict disease transition. Arch Gen Psychiatry. 2009;66:700-712.
5. Orrù G, Pettersson-Yeo W, Marquand AF, Sartori G, Mechelli A. Using Support Vector Machine to identify imaging biomarkers of neurological and psychiatric disease: a critical review. Neurosci Biobehav Rev. 2012;36:1140-1152.
6. Schnack HG, Kahn RS. Detecting neuroimaging biomarkers for psychiatric disorders: sample size matters. Front Psychiatry 2016;7:1-12.
7. Insel T, Cuthbert B, Garvey M, et al. Research domain criteria (RDoC): toward a new classification framework for research on mental disorders. Am J Psychiatry. 2010;167:748-751.
8. McGorry P, Nelson B. Why we need a transdiagnostic staging approach to emerging psychopathology, early diagnosis, and treatment. JAMA Psychiatry. 2016;73:191-192.
9. Jablensky A. Subtyping schizophrenia: implications for genetic research. Mol Psychiatry. 2006;11:815-836.
10. Jablensky A. The diagnostic concept of schizophrenia: its history, evolution, and future prospects. Dialogues Clin Neurosci. 2010;12:271-287.
11. Crow TJ. The two-syndrome concept: origins and current status. Schizophr Bull. 1985;11:471-486.
12. Farmer AE, McGuffin P, Spitznagel EL. Heterogeneity in schizophrenia: a cluster-analytic approach. Psychiatry Res. 1983;8:1-12.
13. Dollfus S, Everitt B, Ribeyre JM, Assouly-Besse F, Sharp C, Petit M. Identifying subtypes of schizophrenia by cluster analyses. Schizophr Bull. 1996;22:545-555.
14. Carpenter WT Jr, Heinrichs DW, Wagman AM. Deficit and nondeficit forms of schizophrenia: the concept. Am J Psychiatry. 1988;145:578-583.
15. Koutsouleris N, Gaser C, Jäger M, et al. Structural correlates of psychopathological symptom dimensions in schizophrenia: a voxel-based morphometric study. Neuroimage. 2008;39:1600-1612.
16. Nenadic I, Sauer H, Gaser C. Distinct pattern of brain structural deficits in subsyndromes of schizophrenia delineated by psychopathology. Neuroimage. 2010;49:1153-1160.
17. Nenadic I, Yotter RA, Sauer H, Gaser C. Patterns of cortical thinning in different subgroups of schizophrenia. Br J Psychiatry. 2015;206:479-483.
18. Voineskos AN, Foussias G, Lerch J, et al. Neuroimaging evidence for the deficit subtype of schizophrenia. JAMA Psychiatry. 2013;70:472-480.
19. Insel TR, Cuthbert BN. Medicine. Brain disorders? Precisely. Science. 2015;348:499-500.
20. Fair DA, Bathula D, Nikolas MA, Nigg JT. Distinct neuropsychological subgroups in typically developing youth inform heterogeneity in children with ADHD. Proc Natl Acad Sci U S A. 2012;109:6769-6774.
21. Paulsen JS, Heaton RK, Sadek JR, et al. The nature of learning and memory impairments in schizophrenia. J Int Neuropsychol Soc. 1995;1:88-99.
22. Wu MJ, Mwangi B, Bauer IE, et al. Identification and individualized prediction of clinical phenotypes in bipolar disorders using neurocognitive data, neuroimaging scans and machine learning. Neuroimage. 2017;145:254-264.
23. Arnedo J, Svrakic DM, Del Val C, et al.; Molecular Genetics of Schizophrenia Consortium. Uncovering the hidden risk architecture of the schizophrenias: confirmation in three independent genome-wide association studies. Am J Psychiatry. 2015;172:139-153.
24. Du Y, Pearlson GD, Liu J, et al. A group ICA based framework for evaluating resting fMRI markers when disease categories are unclear: application to schizophrenia, bipolar, and schizoaffective disorders. Neuroimage. 2015;122:272-280.
25. Clementz BA, Sweeney JA, Hamm JP, et al. Identification of Distinct Psychosis Biotypes Using Brain-Based Biomarkers. Am J Psychiatry. 2016;173:373-384.
26. Mwangi B, Soares JC, Hasan KM. Visualization and unsupervised predictive clustering of high-dimensional multimodal neuroimaging data. J Neurosci Methods. 2014;236:19-25.
27. Marquand AF, Rezek I, Buitelaar J, Beckmann CF. Understanding heterogeneity in clinical cohorts using normative models: beyond case-control studies. Biol Psychiatry. 2016;80:552-61.
28. Drysdale AT, Grosenick L, Downar J, et al. Resting-state connectivity biomarkers define neurophysiological subtypes of depression. Nat Med. 2017;23:28-38.
29. Varol E, Sotiras A, Davatzikos C. HYDRA: revealing heterogeneity of imaging and genetic patterns through a multiple max-margin discriminative analysis framework. Neuroimage. 2017;145:346-364.]
30. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13:261-276.
31. Kane JM. Schizophrenia. N Engl J Med. 1996;334:34-41.
32. Woods SW. Chlorpromazine equivalent doses for the newer atypical antipsychotics. J Clin Psychiatry. 2003;64:663-667.
33. Ashburner J. A fast diffeomorphic image registration algorithm. Neuroimage. 2007;38:95-113.
34. Koutsouleris N, Meisenzahl EM, Borgwardt S, et al. Individualized differential diagnosis of schizophrenia and mood disorders using neuroanatomical biomarkers. Brain. 2015;138:2059-2073.
35. Bezdek JC, Ehrlich R, Full W. FCM - the fuzzy C-means clustering algorithm. Comput Geosci. 1984;10:191-203.
36. Dwyer DB, Harrison BJ, Yücel M, et al. Large-scale brain network dynamics supporting adolescent cognitive control. J Neurosci. 2014;34:14096-14107.
37. Fornito A, Harrison BJ, Zalesky A, Simons JS. Competitive and cooperative dynamics of large-scale brain functional networks supporting recollection. Proc Natl Acad Sci U S A. 2012;109:12788-12793.
38. Lancichinetti A, Fortunato S. Consensus clustering in complex networks. Sci Rep. 2012;336:1-7.
39. Filzmoser P, Liebmann B, Varmuza K. Repeated double cross validation. J Chemometr. 2009;23:160-171.
40. Chang CC, Lin CJ. LIBSVM: a library for support vector machines. Acm T Intel Syst Tec. 2011;2:1-27.
41. He HB, Garcia EA. Learning from imbalanced data. Ieee T Knowl Data En. 2009;21:1263-1284.
42. McNemar Q. Note on the sampling error of the difference between correlated proportions or percentages. Psychometrika. 1947;12:153-157.
43. Troyanskaya O, Cantor M, Sherlock G, et al. Missing value estimation methods for DNA microarrays. Bioinformatics. 2001;17:520-525.
44. Guyon I, Elisseeff A. An introduction to variable and feature selection. J Mach Learn Res 2003;3:1157-1182.
45. Cannon TD, Yu C, Addington J, et al. An individualized risk calculator for research in prodromal psychosis. Am J Psychiatry 2016;173:980-988.
46. Lovibond K, Jowett S, Barton P, et al. Cost-effectiveness of options for the diagnosis of high blood pressure in primary care: a modelling study. Lancet. 2011;378:1219-1230.
47. Kambeitz J, Cabral C, Sacchet MD, et al. Detecting neuroimaging biomarkers for depression: a meta-analysis of multivariate pattern recognition studies. Biol Psychiatry. 2017;82:330-338.
48. Zhang T, Koutsouleris N, Meisenzahl E, Davatzikos C. Heterogeneity of structural brain changes in subtypes of schizophrenia revealed using magnetic resonance imaging pattern analysis. Schizophr Bull. 2015;41:74-84.
49. Lahti AC, Holcomb HH, Medoff DR, Tamminga CA. Ketamine activates psychosis and alters limbic blood flow in schizophrenia. Neuroreport. 1995;6:869-872.
50. Williams LM, Das P, Harris AW, et al. Dysregulation of arousal and amygdala-prefrontal systems in paranoid schizophrenia. Am J Psychiatry. 2004;161:480-489.
51. Yamasaki S, Yamasue H, Abe O, et al. Reduced planum temporale volume and delusional behaviour in patients with schizophrenia. Eur Arch Psychiatry Clin Neurosci. 2007;257:318-324.
52. Dolan RJ, Bench CJ, Liddle PF, et al. Dorsolateral prefrontal cortex dysfunction in the major psychoses; symptom or disease specificity? J Neurol Neurosurg Psychiatry. 1993;56:1290-1294.
53. Lawrie SM, Buechel C, Whalley HC, Frith CD, Friston KJ, Johnstone EC. Reduced frontotemporal functional connectivity in schizophrenia associated with auditory hallucinations. Biol Psychiatry. 2002;51:1008-1011.
54. Nishimura Y, Takizawa R, Muroi M, Marumo K, Kinou M, Kasai K. Prefrontal cortex activity during response inhibition associated with excitement symptoms in schizophrenia. Brain Res. 2011;1370:194-203.
55. Yoon JH, Minzenberg MJ, Ursu S, et al. Association of dorsolateral prefrontal cortex dysfunction with disrupted coordinated brain activity in schizophrenia: relationship with impaired cognition, behavioral disorganization, and global function. Am J Psychiatry. 2008;165:1006-1014.
56. Lin A, Reniers RL, Wood SJ. Clinical staging in severe mental disorder: evidence from neurocognition and neuroimaging. Br J Psychiatry Suppl. 2013;54:s11-s17.
57. McGorry PD, Hickie IB, Yung AR, Pantelis C, Jackson HJ. Clinical staging of psychiatric disorders: a heuristic framework for choosing earlier, safer and more effective interventions. Aust N Z J Psychiatry. 2006;40:616-622.
58. Ho BC, Andreasen NC, Ziebell S, Pierson R, Magnotta V. Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia. Arch Gen Psychiatry. 2011;68:128-137.
59. Ansell BR, Dwyer DB, Wood SJ, et al. Divergent effects of first-generation and second-generation antipsychotics on cortical thickness in first-episode psychosis. Psychol Med. 2015;45:515-527.